ARCHIVES

Centocor Withdraws Yondelis After FDA Calls for New Study

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

Michael Friedman To Head PhRMA’s Office Of Biomedical Preparedness.

November 2, 2001

From One Competitive Market to Another: UC San Diego Stakes A Claim in Las Vegas

January 27, 2012

5-FU/Levamisole A community Success Story; Trials With Untreated Control Revised Or Dropped

October 13, 1989

On “Day One Of Post-Genome World,” Eric Lander Recounts 15-Year Journey.

February 16, 2001

Groups Urge Passage of Health Care Reform Legislation

January 29, 2010

NIH Sets Tuition Cost Policy For NRSA Grants

February 9, 1996